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Regulation of type-II collagen gene expression during human chondrocyte
de-differentiation and recovery of chondrocyte-specific phenotype in culture
involves Sry-type high-mobility-group box (SOX) transcription factors
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During ex io growth as monolayer cultures, chondrocytes
proliferate and undergo a process of de-differentiation. This
process involves a change in morphology and a change from
expression of chondrocyte-specific genes to that of genes that are
normally expressed in fibroblasts. Transfer of the monolayer
chondrocyte culture to three-dimensional culture systems induces
the cells to re-acquire a chondrocyte-specific phenotype and
produce a cartilaginous-like tissue in itro. We investigated
mechanisms involved in the control of the de-differentiation and
re-differentiation process in itro. De-differentiated chondro-
cytes re-acquired their chondrocyte-specific phenotype when
cultured on poly-(2-hydroxyethyl methacrylate) (polyHEMA) as
assayed by morphology, reverse transcriptase PCR of chondro-
cyte-specific mRNA, Western-blot analysis and chondrocyte-
specific promoter activity. Essentially, full recovery of the
chondrocyte-specific phenotype was observed when cells that had
been cultured for 4 weeks on plastic were transferred to culture
INTRODUCTION
Cartilage is a complex tissue containing a unique set of extra-
cellular matrix molecules that provide the tissue with its ability to
withstand compression and frictional stresses associated with
joint movement [1–4]. The composition of the cartilage extra-
cellular matrix is governed by chondrocytes, which express
cartilage-specific genes in response to an intricate array of
regulatory signals, including those that occur during development
and tissue repair [5–7]. Following the pioneering studies of Benya
and colleagues [8–10] on the phenotypic changes of rabbit
chondrocytes in culture, modulation of the morphological and
biosynthetic phenotype of cartilage cells has been the subject of
intensive investigations. Numerous studies have examined the
plasticity of the chondrocyte phenotype, employing cells of
human, avian, lapine and rodent origin. It has become apparent
from these collective studies that culturing chondrocytes as
an adherent monolayer invariably leads to a process of de-
differentiation whereby the cells acquire a fibroblastic morpho-
logy and lose their chondrocyte-specific gene-expression
pattern [8–21]. Specifically, when chondrocytes are cultured in
monolayers there is a prompt down-regulation of the expression
of cartilage-specific genes, such as those encoding type-II, -IX
Abbreviations used: b-Gal, b-galactosidase ; CAT, chloramphenicol acetyltransferase ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
polyHEMA, poly-(2-hydroxyethyl methacrylate) ; SOX, Sry-type high-mobility-group box; L-SOX5, long-form SOX5; DMEM, Dulbecco’s minimal
essential medium; FBS, fetal bovine serum; P, passage; RT, reverse transcriptase ; DTT, dithiothreitol ; SV40, simian virus 40 ; EMSA, electrophoretic
mobility-shift assay.
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on polyHEMA. However, after subsequent passages on plastic,
the phenotype recovery was incomplete or did not occur. The
activity of a gene reporter construct containing the promoter and
enhancer from the human type-II collagen gene (COL2A1) was
modulated by the culture conditions, so that its transcriptional
activity was repressed in monolayer cultures and rescued to some
extent when the cells were switched to polyHEMA cultures. The
binding of Sry-type high-mobility-group box (SOX) transcription
factors to the enhancer region was modulated by the culture
conditions, as were the mRNA levels for SOX9. A transfected
human type-II collagen reporter construct was activated in de-
differentiated cells by ectopic expression of SOX transcription
factors. These results underscore the overt change in phenotype
that occurs when chondrocytes are cultured as monolayers on
tissue-culture plastic substrata.
Key words: cartilage, COL2A1 gene, enhancer.
and -XI collagens and aggrecan, and a concomitant initiation or
up-regulation of the expression of fibroblast-associated genes
such as those for type-I, -III and -V collagens and versican
[8–21]. The cells re-acquire their chondrocyte-specific phenotype
when transferred to a non-adherent, three-dimensional culture
system, such as cultures in agarose or alginate beads, or in
suspension on a hydrogel substrate [12,18,21–29]. However, the
molecular mechanisms governing this process are not well
understood.
We have previously established a human chondrocyte culture
system that allows examination of the reversible loss of the
chondrocyte-specific phenotype and its subsequent recovery in a
predictable manner [28,29]. Furthermore, we have shown that
the morphological and biochemical changes associated with these
processes are accompanied by remarkable changes in the levels
of DNA-binding nuclear proteins that specifically interact with
important regulatory regions in the promoter of the cartilage-
specific type II collagen gene COL2A1 [30]. In the present work
we investigated further the plasticity of the chondrocyte-specific
phenotype afforded by this system by testing whether the de-
differentiated phenotype of chondrocytes grown as a monolayer
for varying periods can be fully reversed upon return to the poly-
(2-hydroxyethyl methacrylate) (polyHEMA) culture system. We
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show that the recovery of the chondrocyte-specific phenotype
following growth as a monolayer is dependent on the number of
passages. Furthermore, we show that the phenotypic changes are
accompanied by modulation of the transcriptional activity of a
COL2A1 promoter}enhancer gene construct and that differences
in Sry-type high-mobility-group box (SOX) transcription factor
binding to a COL2A1 enhancer segment also occur. We also
found that the expression of a human type-II collagen reporter
construct was activated in de-differentiated chondrocytes by
ectopic expression of long-form SOX5 (L-SOX5), SOX6
and SOX9. The SOX transcription factors SOX6, SOX9 and
L-SOX5 have been shown previously to be important for acti-
vation of the COL2A1 gene during chondrogenesis in mice and
for expression of the COL2A1 gene in both human and mouse
primary chondrocytes [31–35]. Skeletal formation is dependent
on SOX9, as mutations in the human SOX9 gene cause campo-
melic dysplasia, a disease associated with abnormal skeletal
structures [36,37]. SOX9 has also been shown to be down-
regulated by pro-inflammatory cytokine treatment of chondro-
cytes and is therefore implicated in inflammatory joint diseases
[38]. Thus the SOX factors (L-SOX5, SOX6 and SOX9) are
thought to be master regulatory genes that are essential for the
expression of the chondrocyte-specific phenotype. Therefore
the results presented in this work provide the foundation for
further studies that may allow an improved preservation and
recovery of the chondrocyte phenotype in itro.
EXPERIMENTAL
Isolation of human fetal and bovine fetal chondrocytes
Human fetal chondrocytes were obtained from epiphyseal car-
tilage removed under sterile conditions from femoral heads, knee
condyles and tibial plateaux of 20–24-week-old fetuses. The
tissues were obtained from the Anatomical Gift Foundation
(Laurel, MD, U.S.A.). To remove adherent fibrous tissues, the
cartilage was incubated in Hank’s medium containing trypsin
and bacterial collagenase (2 mg}ml each) for 1 h at 37 °C. The
medium was discarded and the tissue fragments minced and
digested overnight at 37 °C in Dulbecco’s minimal essential
medium (DMEM) with 4.5 g}l glucose containing 10% fetal
bovine serum (FBS) and 0.5 mg}ml of bacterial collagenase. The
released cells were filtered through a 70 lm nylon membrane into
a vessel containing fresh DMEM and 10% FBS. The cells were
collected by centrifugation at 250 g for 5 min and washed four
times with collagenase-free medium. The average yield of
chondrocytes obtained with this procedure was (3.0‡0.4)‹
10) chondrocytes}g of cartilage (wet weight). For experiments
employing fetal bovine chondrocytes, articular cartilage from
second trimester bovine fetuses was obtained from Animal
Technologies (Tyler, TX, U.S.A.) and the chondrocytes were
liberated as above. The yield of chondrocytes from the fetal
bovine cartilage was 1‹10) chondrocytes}g of wet cartilage.
Culture of chondrocytes
The isolated chondrocytes were cultured in DMEM containing
10% FBS, 2 mM glutamine, 1% vitamin supplements and
40 lg}ml ascorbic acid. This medium was employed because it
was found in previous studies to cause a rapid and consistent loss
of the cartilage-specific phenotype and a conversion of chondro-
cytes into cells with fibroblastic characteristics when cultured in
plastic culture dishes. It also allowed for the maintenance of the
chondrocyte-specific phenotype for long periods when the cells
were cultured on polyHEMA-coated dishes [28,29]. To induce
the loss of the chondrocyte-specific phenotype in the human fetal
Scheme 1 Experimental protocol for investigating the de-differentiation/re-
differentiation process in cultured human chondrocytes
chondrocytes and bovine fetal chondrocytes the isolated cells
were plated into plastic tissue culture dishes and were cultured
until confluent [passage (P) 0]. The cells were then dissociated
with trypsin and collagenase and subcultured (1:2) in new
plastic dishes for 4 weeks (P1). These cells were subcultured on
plastic twice more at 4 week intervals (P2 and P3). To attain
recovery of the chondrocyte-specific phenotype of the de-
differentiated cells, cells from the monolayer cultures on tissue-
culture plastic substrata at P1, P2 and P3 were trypsinized and
plated at a density of 5‹10’ cells in 60 mm plastic Petri dishes
that had been coated previously with 0.9 ml of a 10% solution
of polyHEMA (Poly Sciences, Malvern, PA, U.S.A.) as described
previously [28,29]. Following each sequential passage on tissue-
culture plastic, the cells were cultured on the polyHEMA
substrata for 4 weeks to allow the recovery of their chondrocyte-
specific phenotype (P1r, P2r and P3r). A flow-chart for this
experimental protocol is depicted in Scheme 1. For the trans-
fection experiments involving bovine fetal chondrocytes the
cells were initially plated at a density of 30000}cm# on tissue-
culture plastic and cultured for 11 days, when they were
transiently transfected using the Profection kit (Promega,
Madison, WI, U.S.A.) as described below.
Reverse transcriptase (RT)-PCR amplification of COL2A1,
COL11A2 and aggrecan from chondrocytes cultured on either
polyHEMA or plastic substrates
Total RNA was isolated from chondrocytes under the various
culture conditions described above using the Trizol reagent
(Gibco BRL, Rockville, MD, U.S.A.). RT-PCR was carried out
utilizing the GeneAmp RNA PCR kit (Perkin Elmer, Norfolk,
CT, U.S.A.). The reverse transcription and PCR were carried out
with the primers shown in Table 1 using the following conditions:
95 °C for 2 min followed by 95 °C for 45 s, 56 °C for 1 min and
72 °C for 1 min 5 s for 35 cycles. The PCR products were
analysed by agarose-gel electrophoresis. An RNA dot-blot
hybridization with glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as a probe was carried out and quantified with a
PhosphorImager and Imagequant software (Molecular Dyna-
mics, Sunnyvale, CA, U.S.A.) to ensure that equal amounts of
RNA were used in the RT-PCR reaction.
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Table 1 Primers utilized for RT-PCR amplification of COL2A1, COL11A1,
COL1A1, COL3A1 and aggrecan cDNA
Gene Primer sequence (5«! 3«) Nucleotide location
Expected product
size
COL2A1 AAGATGGTCCCAAAGGTGCTCG 2567–2588 500 nt
AGCTTCTCCTCTGTCTCCTTGC 3066–3045
COL11A1 ATGGAAGCCGTCTGATGC 50C–67C 410 nt
GTAGGAGACGTCCTGCTG 459C–442C
Aggrecan AGAGAAGATTCTGGGTC 793–810 657 nt
AGCATCCACCCAGGTCT 1449–1432
COL1A1 TAAAGGGTCACCGTGGCT 3439–3456 355 nt
CGAACCACATTGGCATCA 3793–3776
COL3A1 CATCTTGGTCAGTCCTATGCGGAT 202–225 399 nt
TACTGCTACTCCAGACTTGACATC 600–577
Western-blot analysis
For Western-blot analysis, chondrocytes cultured under the
various conditions described above were suspended and then
centrifuged at 1500 g for 5 min and washed twice with PBS. The
cells were re-suspended in 1% SDS}50 mM dithiothreitol
(DTT)}1% (v}v) glycerol and heated to 100 °C for 5 min. The
solubilized cell-associated proteins were separated by electro-
phoresis in 6% polyacrylamide gels on a mini-gel apparatus at
125 V for 90 min. The proteins were electroblotted at 40 V for
90 min from the polyacrylamide gel on to a supported nitro-
cellulose membrane and the transferred proteins were incubated
for 30 min with a 1:500 dilution (v}v) of SJ441 antibody, a
polyclonal antibody that recognizes the C-terminal telopeptide
of human type-II collagen and also cross-reacts with the a2
chain of type-XI collagen [30]. The proteins on the filter were
detected using the ECL2 Western-blotting detection reagent
(Amersham, Arlington Heights, IL, U.S.A.).
Transient transfection, chloramphenicol acetyltransferase (CAT)
assays and Northern-blot analyses
The human fetal chondrocytes were transfected with 30 lg of the
various reporter constructs by the calcium phosphate precipi-
tation method using the Profection kit (Promega), followed 16 h
later by a 15% glycerol shock for 1 min. Fresh medium was
added and the cells were harvested 48 h after transfection and
lysed by sonication. Total protein was measured by the Bradford
assay [39]. CAT activity was determined in cell extracts by TLC
[40] and quantified by PhosphorImager using Imagequant soft-
ware (Molecular Dynamics). The level of CAT activity was
normalized to the amount of b-galactosidase (b-Gal) activity by
co-transfection with a simian virus 40 (SV40)–b-Gal construct
(pSV-b-Galactosidase Control Vector ; Promega) in the reversal
experiments. For determination of b-Gal activity the b-Gal
enzyme assay system from Promega was utilized. The COL2A1
promoter–CAT constructs used for experiments shown in Figure
4 (see below) were a gift from Mary Goldring (Harvard Medical
School, Boston, MA, U.S.A.) [41]. pB}4.0 contains from fi577
to ›3248 bp and pB}2.9 contains from fi577 to ›2370 bp of
the human COL2A1 gene linked to the CAT gene. The region
from ›2497 to ›3428 bp contains the chondrocyte-specific
enhancer region [42]. pE}0.7 and pE}0.2 contain from fi577 to
›63 bp and fi131 to ›63 bp of the human COL2A1 gene
linked to the CAT gene, respectively, and also contain the SV40
enhancer region.
Bovine chondrocytes cultured in six-well plateswere transiently
transfected using the FuGene reagent (Roche) with 1.5 lg of the
human COL2A1–luciferase reporter construct and either 0.5 lg
of pCDNA3 vector alone or 0.5 lg of either the L-SOX5, SOX6
or SOX9 expression constructs alone or 0.25 lg each of the
L-SOX5, SOX6 and SOX9 expression constructs together. All
transfections included 0.5 lg of pCMV-bGAL (Clontech, Palo
Alto, CA, U.S.A.) as a control for transfection efficiency. The
human COL2A1–luciferase construct contains from fi531 to
›63 bp of the promoter region linked to the luciferase reporter
gene followed by the region from ›1286 to ›4011 bp from the
first intron, which contains the enhancer [42]. After addition of
the FuGene}DNA mix (48 h) the cells were harvested and both
b-Gal and luciferase activities were determined using assay kits
from Promega. Luciferase activity was normalized to both
protein amount and b-Gal activity.
Preparation of nuclear extracts and electrophoretic mobility-shift
assays (EMSAs)
Nuclear extracts from differentiated and de-differentiated
chondrocytes were prepared by standard methods [43] with
minor modifications as described previously [29]. Briefly, cells
were lysed by Dounce homogenization in hypotonic buffer
(10 mM Hepes, pH 7.9, 1.5 mM MgCl
#
, 10 mM KCl, 0.2 mM
PMSF and 0.5 mM DTT). Nuclei were recovered by centri-
fugation at 3300 g for 15 min at 4 °C and their volume estimated.
The nuclei were then resuspended in a volume of low-salt buffer
(20 mM Hepes, pH 7.9, 25% glycerol, 1.5 mM MgCl
#
, 20 mM
KCl, 0.2 mM EDTA, 0.2 mM PMSF and 0.5 mM DTT) equal to
one-half the estimated volume of pelleted nuclei. High-salt buffer
(same as low-salt buffer except that 1.2 M KCl was used) was
added slowly until the final KCl concentration was 0.4–0.6 M.
The nuclei were extracted for 30 min at 4 °C with gentle stirring.
The extract was centrifuged for 30 min at 25000 g and then the
supernatantwas dialysed against 50 vol. of dialysis buffer (20 mM
Hepes, pH 7.9, 20% glycerol, 100 mM KCl, 0.2 mM PMSF and
0.5 mM DTT) overnight at 4 °C. Protein concentration was
determined by absorbance at 280 nm.
EMSAs were carried out as follows. The 84 bp COL2A1
enhancer probe (probe 45}46; see Figure 5A, below) was
synthesized by PCR with the primers DS45 (5«-CTGGTTCCT-
CGCAGAGAC-3«) and DS46 (5«-AACCCACTGGACCTCG-
TC-3; positions 2190–2273 in COL2A1) and the plasmid pB}4.0
as a template [41,42,44]. These primers flank a region in the first
intron of human COL2A1 that is homologous to the mouse
48 bp enhancer sequence described by Lefebvre et al. [33]. The
probe was $#P-end-labelled by T4 polynucleotide kinase. Binding
reactions consisted of 12.5 mM Hepes, pH 7.9, 50 mM KCl, 5%
glycerol, 2 mg}ml BSA, 1–2 lg of poly(dG-dC), 0.1 mM EDTA,
0.1 mM DTT, 3–5 ng of labelled probe and 10–15 lg of nuclear
protein. For competition experiments, a 100-fold excess of
unlabelled 45}46 probe or unlabelled high-mobility-group
(HMG) consensus probe was added. The HMG consensus probe
was a double-stranded oligonucleotide prepared from the fol-
lowing oligonucleotides : DS33, 5-GGACACTGAGAACAAA-
GCGCTCTCAC-3«, and DS34, 5-GGGTGAGAGCGCTTTG-
TTCTCAGTGT-3« [33]. For supershift assays, 1 ll of anti-
L-SOX5, anti-SOX6 or anti-SOX9 antibodies was added to the
binding reactions. The antibodies were a gift from Dr Veronique
Lefebvre (University of Texas, M. D. Anderson Cancer Center,
Houston, TX, U.S.A.) [34]. Binding reactions were incubated at
room temperature for 30 min and then loaded on to 5% TAE
(40 mM Tris}acetate}1 mM EDTA) polyacrylamide gels. Gels
were electrophoresed at 140 V for 2–3 h, vacuum dried and
exposed to X-ray film at fi70 °C.
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RESULTS
Morphological appearance of chondrocytes cultured under
conditions that allow the loss of the chondrocyte-specific
phenotype and its subsequent recovery
The morphological appearance of the chondrocytes is shown in
Figure 1. The loss of chondrocyte morphology and the acquisition
of fibroblastic shape was progressively apparent as the cells were
subcultured on plastic. Recovery of the spherical shape mor-
phology was observed when the fibroblast-like cells from P1 and
P2 were transferred to polyHEMA-coated dishes (P1r, P2r;
Figure 1). The P1r cells were photographed at an earlier time
point during the re-differentiation process and had not yet
formed the clusters observed in the P2r cells, which were
photographed at a later stage. P1r cells were observed to form
clusters at later time points (results not shown). However,
fibroblast-like cells from P3 failed to fully re-acquire the
chondrocyte shape when transferred to the suspension culture
(P3r; Figure 1).
Analysis of chondrocyte-specific gene expression
In order to determine the effect of the culture conditions on the
chondrocyte-specific gene expression pattern, RT-PCR analysis
was performed on RNA isolated from the cells at the different
Figure 1 Morphological appearance of human chondrocytes under culture
conditions for de-differentiation and re-differentiation
Morphological appearance of human fetal epiphyseal chondrocytes plated on plastic-coated
dishes as primary cultures for 1 week (P0), during sequential sub-passages to plastic dishes
(P1–P3), or following transfer from the plastic dishes to polyHEMA-coated dishes at each of
the indicated passages (P1r–P3r).
Figure 2 RT-PCR analysis of collagen and aggrecan gene expression
(A) RT-PCR of total RNA from chondrocytes shown in Figure 1 for the expression of the
COL11A1 [a1(X1)] and aggrecan genes. (B) RT-PCR of total RNA from another experiment in
which the cells were taken to P2r. RNA was isolated and subjected to RT-PCR utilizing the
primers described in the Experimental section for COL2A1 [a1(II)] and COL11A1 [a1(X1)]
mRNA. (C) RT-PCR of total RNA from the same cells shown in (B) with primers designed to
detect transcripts from the COL1A1 [a1(I)] and COL3A1 [a1(III)] genes.
passages on plastic and following their transfer to polyHEMA.
Primers were used that would specifically amplify human
COL2A1, COL11A2 and aggrecan transcripts, three chondro-
cyte-specific gene products (Table 1). Two independent experi-
ments were analysed in this manner. As shown in Figure 2,
the pattern of expression of these genes was modulated by the
culture conditions. In the experiment shown in Figure 2(A),
the expression of COL11A1 mRNA in chondrocytes cultured
on plastic diminished in P1 and P2 cells and was essentially
undetectable in P3 cells. Aggrecan mRNA expression was lost by
P2 on plastic. When cells from P2 on plastic were cultured on
polyHEMA (P2r) the expression of COL11A1 and aggrecan
mRNAs returned to the levels observed in P0 cells ; however,
COL2A1 mRNA expression, although higher, remained below
the levels found in P0 cells (results not shown). When P3 cells
were transferred to polyHEMA (P3r), the expression of both
COL11A1 and aggrecan was restored, whereas COL2A1 mRNA
expression was not detected in P3r cells (results not shown).
In another experiment (Figure 2B) the expression of COL2A1
and COL11A1 mRNA was analysed in P1 and P2 cells (on
plastic) and following their culture on polyHEMA (P1r and P2r).
In this experiment, the expression of the two genes also closely
mirrored the culture conditions. P1 cells on plastic lost the
expression of COL11A1, and COL2A1 expression was
diminished compared with P0 cells. When P1 cells were switched
to polyHEMA for 4 weeks (P1r), expression of both genes
returned to the levels observed in P0 cells. COL2A1 mRNA in P2
cells on plastic was lower, as compared with P0 cells, and
COL11A1 mRNA was reduced even further. When P2 cells were
transferred to polyHEMA for 4 weeks (P2r cells) the expression
of COL11A1 was seen to return to near the levels observed in P0
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Figure 3 Western-blot analysis of collagen protein expression
Western-blot analysis of a1(II) and a2(XI) collagen chains in extracts from chondrocytes shown
in Figure 1. A polyclonal antibody which recognizes the C-terminal telopeptide of a1(II) collagen
and cross-reacts with the a2(XI) collagen chain [30] was employed as described in the
Experimental section.
cells whereas, as was observed in the experiment in Figure 2(A),
COL2A1 mRNA levels remained lower. In a third experiment,
shown in Figure 2(C), the expression levels of the COL1A1 and
COL3A1 genes, which are more highly expressed in de-
differentiated cells, were investigated by employing RT-PCR.
The expression patterns of those genes were again reflective of
the culture conditions in that they were more highly expressed
in the de-differentiated chondrocytes (P1 and P2) compared with
the differentiated chondrocytes (P0, P1r and P2r).
Recovery of the cartilage-specific phenotype was also investi-
gated by performing Western-blot analysis to ascertain the level
of production of a1 type-II and a2 type-XI collagen chains.
As shown in Figure 3 the expression of these chains diminished
progressively with subsequent passages on plastic (P1–P3),
whereas there was an increase in their expression in P2r cells (4
weeks on polyHEMA after two passages on plastic over 8 weeks)
compared with both P2 and P3 cells. However, the expression of
the cartilage-specific collagens did not recover to the levels seen
in either P0 and P1 cells. P3r cells (4 weeks on polyHEMA after
three passages over 12 weeks on plastic) exhibited detectable
although diminished amounts of both collagens, which were
undetectable in cells passaged three times on plastic (P3).
Effects of different culture conditions on COL2A1 promoter activity
Based on the results obtained from the RT-PCR and Western-
blot experiments and our previous findings of differences in
transcription-factor expression patterns between chondrocytes
cultured on plastic and polyHEMA [29], we next determined
whether the modulation of COL2A1 mRNA expression was
controlled at the transcriptional level. For this experiment, cells
cultured under conditions that either led to their de-
differentiation into fibroblast-like cells or allowed them to recover
their chondrocyte-specific phenotype were transiently transfected
with constructs containing the COL2A1 promoter either with or
without the first-intron enhancer region linked to the CAT
reporter gene. The constructs employed for transfections were
those described previously by Goldring et al. [41] and are depicted
in Figure 4(A). We first performed an initial experiment in which
we transfected chondrocytes that had been cultured on either
polyHEMAor plastic in comparison with human skin fibroblasts.
The results of this experiment are shown in Figure 4(B). We
observed that only chondrocytes cultured on polyHEMA showed
a high level of expression of the pB}4.0 construct, which contains
both the promoter and enhancer regions of COL2A1. The other
three constructs, pB}2.9, pE}0.7 and pE}0.2, showed equally
low expression levels, although there was a small variation in
expression of pB}2.9 between the three cell types. Since high-
level expression was dependent on inclusion of the enhancer
sequences present in the pB}4.0 construct (Figure 4A), we next
investigated the differences in expression levels of the pB}4.0 and
pB}2.9 constructs in chondrocytes that had been re-differentiated
by transfer from monolayer culture to polyHEMA-coated dishes.
We transfected P0, P1, P1r, P2 and P2r cells (see Scheme 1) with
pB}4.0, pB}2.9 or pSV2-CAT. The results of this experiment are
shown in Figure 4(C). There was very little difference in CAT
activity between the chondrocytes cultured on plastic or
polyHEMA when transfected with the pSV2-CAT control
construct. However, when the construct pB}4.0 containing
the COL2A1 promoter and first-intron enhancer was used, the
resulting CAT activity was reflective of the differentiation}de-
differentiation state of the cells (Figure 4C), with a high level of
expression in cells cultured on polyHEMA in contrast to the very
low levels observed in cells cultured on plastic. Interestingly,
when construct pB}2.9 lacking the enhancer region was
examined, no differences in CAT activity were observed between
the cells cultured on either plastic or re-differentiated on
polyHEMA (Figure 4C). These results indicate that the decrease
in COL2A1 gene expression observed during the de-
differentiation process, which chondrocytes undergo as a result
of culture in monolayers on plastic, is controlled largely at the
level of transcription of the gene and that this control is dependent
on the presence of the first-intron enhancer region.
Changes in nuclear-factor binding to the COL2A1 enhancer during
de-differentiation
The transfection results indicated that the enhancer region of the
COL2A1 gene was important for the regulation observed between
the different culture conditions. It is known that members of the
SOX family of transcription factors regulate the human COL2A1
gene in chondrocytes through binding sites within the enhancer
region [31]. A 48 bp region found in the mouse COL2A1
enhancer region, which is conserved in the human gene, contains
four SOX-protein binding sites, binds to three different SOX
factors (SOX6, SOX9 and L-SOX5) and has been shown to be
important for the chondrocyte-specific expression of this gene
[34]. We therefore examined whether the interaction of these
factors with the corresponding region from the human gene was
altered in response to de-differentiation. For this purpose, nuclear
extracts were prepared from human fetal chondrocytes grown on
polyHEMA dishes or from chondrocytes cultured and passaged
as monolayers on tissue-culture plastic at 1 week intervals for up
to 4 weeks. An 84 bp probe was synthesized by PCR from the
human COL2A1 gene that contained the conserved SOX binding
sites as delineated in the mouse gene and this probe was used in
an electrophoretic mobility-supershift assay (Figure 5A). Figure
5(B) shows that the pattern of nuclear-factor binding to this
probe changes after four sequential 1-week passages. The
DNA–protein complexes from the cells cultured on plastic for
either 1 or 4 weeks displayed slower electrophoretic mobility in
comparison with the pattern displayed by complexes from P0
chondrocytes (Figure 5B, lanes 1–3, bracket). Supershift analysis
with antibodies against L-SOX5 and SOX6 resulted in a partial
shift of nuclear extracts from P0 chondrocytes and chondrocytes
cultured on plastic for 1 or 4 weeks (Figure 5B, lanes 4–9, arrow).
We observed the strongest shift and an apparent disruption in
the DNA–protein complex in P0 extracts with the SOX9 anti-
bodies (Figure 5B, lane 10). Supershift analysis with the
anti-SOX9 antibodies employing nuclear extracts isolated from
1 and 4 week cells also showed partial shifts (Figure 5B, lanes 11
and 12, arrow), consistent with the partial activity of the COL2A1
gene observed in chondrocytes cultured for 4 weeks inmonolayers
(P1, Figures 2 and 4). However, the anti-SOX9 antibodies
resulted in a weaker shift of the DNA–protein complex in 1- and
4-week extracts (Figure 5B, lanes 11 and 12) compared with the
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Figure 4 COL2A1 reporter constructs and transient-transfection analyses of differentiated, de-differentiated and re-differentiated human chondrocytes
(A) Schematic representation of the human COL2A1 enhancer–CAT reporter constructs that were transfected into de-differentiating and re-differentiating chondrocytes (see the Experimental section).
(B) CAT activity of the human COL2A1 promoter/enhancer constructs pB/4.0, pB/2.9, pE/0.7 and pE/0.2 in differentiated chondrocytes, de-differentiated chondrocytes and human dermal fibroblasts.
(C) Representative CAT assays of the human COL2A1 promoter/enhancer constructs pB/4.0 and pB/2.9 and the control construct pSV2-CAT (see panel A) in chondrocytes (P0) and chondrocytes
transferred from monolayer cultures (P1, P2) to polyHEMA cultures (P1r, P2r) as outlined in Scheme 1. (D) Quantification of the CAT assays shown in (C). Results shown are from duplicate assays.
Pixel volume/b-gal on the y-axis are counts collected by a PhosphorImager and corrected for b-Gal activity (co-transfection).
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Figure 5 EMSAs and supershift assays of differentiated and de-differentiated human chondrocyte nuclear extracts with a COL2A1 enhancer probe
(A) Sequence comparison of the 84 bp probe used in the EMSA shown in (B) from the human COL2A1 enhancer (H) with the homologous region in the mouse COL2A1 (M). The SOX transcription
factor-binding sites are shown in bold. (B) Electrophoretic mobility-supershift assay with nuclear extracts from human fetal chondrocytes cultured on polyHEMA (C) or on tissue-culture plastic
for either one (1W) or four 1-week passages (4W) with antibodies against L-SOX5, SOX6 and SOX9 and the probe depicted in (A). Nuclear protein (10 lg) from control chondrocytes cultured
on polyHEMA-coated dishes or chondrocytes cultured on tissue-culture plastic for one or four 1-week passages was incubated with 32P-labelled enhancer probe alone (lanes 1–3) or with
anti-L-SOX5, SOX6 or SOX9 antibodies before addition of the labelled probe (lanes 4–12). Bracket, DNA–protein complexes ; arrow, supershifted complexes.
pH   P1 pH   P1 pH   P1
SOX9 SOX6 GAPDH
Figure 6 Northern-blot analysis of total RNA isolated from differentiated
and de-differentiated human chondrocytes hybridized with cDNA probes for
SOX9 and SOX6
Total RNA was isolated from differentiated (pH) or de-differentiated (Pl) human fetal
chondrocytes cultured on polyHEMA or tissue-culture plastic for 11 days, respectively. Each
lane contained 10 lg of total RNA. The blot was also probed with a cDNA for GAPDH as a
control.
P0 nuclear extract (Figure 5B, lane 10). The results indicate that
the process of de-differentiation results in a changed pattern of
nuclear-factor interaction with this region of the human COL2A1
gene enhancer, involving differences in interaction with the SOX
family of transcription factors. To support these results,
SOX9 mRNA levels were examined by Northern-blot analysis
of mRNA isolated from human fetal chondrocytes cultured as
a monolayer or on polyHEMA for 11 days. The results showed a
substantial decrease in the steady-state level of SOX9 transcripts
in comparison with the levels found in chondrocytes cultured on
polyHEMA-coated dishes for the same length of time (Figure 6).
Up-regulation of the COL2A1 gene by expression of SOX proteins
in de-differentiated chondrocytes
To determine whether the down-regulation of COL2A1 gene
expression observed in de-differentiated chondrocytes was due to
the lack of availability of SOX transcription factors, de-
differentiated bovine fetal chondrocytes were transiently trans-
fected with expression constructs for L-SOX5, SOX6 and}or
SOX9 along with a human COL2A1 reporter construct con-
taining the proximal promoter and the enhancer region (Figure
7B). As shown in Figure 7(A), fetal bovine chondrocytes exhibit
the same dramatic down-regulation of type-II collagen mRNA
levels as was observed in human fetal chondrocytes when they
were grown as a monolayer. Fetal bovine chondrocytes were
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Figure 7 Effect of transient transfection of SOX expression plasmids on the
expression levels of a human COL2A1–luciferase reporter construct in de-
differentiated fetal bovine chondrocytes
(A) Northern-blot analysis of total RNA isolated from freshly isolated fetal bovine chondrocytes
(F), cultured on polyHEMA-coated dishes for either 14 days (14) or 21 days (21), or fetal bovine
chondrocytes cultured on plastic tissue-culture flasks for either three passages (P3) over 4
weeks or ten passages (P10) over 10 weeks. The blot was hybridized with cDNA probes for
bovine type-II collagen and human GAPDH (results not shown). The numbers shown below the
lanes represent the fold reduction in COL2A1 mRNA expression compared with freshly isolated
fetal bovine chondrocytes after normalization to the GAPDH mRNA signal. (B) Schematic
depiction of the human COL2A1–luciferase reporter construct. Numbers refer to nucleotide
positions within the human COL2A1 gene with reference to the transcription start site.
(C) Quantification of luciferase activity from the transient-transfection analysis. The bar graph
shows the fold difference in COL2A1–luciferase activity in the de-differentiated bovine fetal
chondrocytes co-transfected with the indicated SOX expression vectors, either alone or together
(SOX5,6,9).
grown as a monolayer for 8 weeks, co-transfected with the SOX
expression constructs and the human COL2A1–luciferase re-
porter construct, and then 48 h later luciferase activity was
determined. We observed a 2.5–3.5-fold increase in the levels of
the COL2A1–luciferase reporter construct in the cells that were
co-transfected with the L-SOX5, SOX6 and SOX9 expression
constructs as compared with cells transfected with vector alone
(Figure 7C).
DISCUSSION
Thewell-known instability of the chondrocyte phenotype remains
a major problem that has hampered in itro studies of
chondrocyte gene expression and of their modulation by cyto-
kines and growth factors, as well as the detailed study of
pharmacological agents that may be capable of modulation
of cartilage matrix production or that may potentially allow re-
generation of cartilage. Indeed, a large number of studies that
have examined the pharmacological modulation of chondrocyte
functions or the effects of cytokines and growth factors on these
cells have employed chondrocytes cultured as monolayers on
plastic substrata that have presumably undergone variable (and
therefore uncontrolled) levels of de-differentiation.
The results presented here document further the plasticity of
the chondrocyte-specific phenotype in itro. We have shown
that the phenotype of human fetal epiphyseal chondrocytes can
be modulated by culturing them as monolayers on plastic
followed by culture on dishes coated with the hydrogel poly-
HEMA. The polyHEMA culture system allows chondrocytes to
maintain or re-acquire their spherical morphology and establish
three-dimensional contacts with other cells, whereas when cul-
tured on plastic, the cells attach to the substratum, spread
and become fibroblastic in appearance [28,29]. The polyHEMA
culture system allowed the re-acquisition of a chondrocyte-
specific morphology and gene-expression pattern following one
4-week passage of culture on plastic. The ability of chondrocytes
to recover their specific phenotype was diminished following two
4-week passages as a monolayer, and was almost totally lost after
three 4-week passages. Other culture systems, such as alginate,
agarose and certain artificial matrices, also allow re-differen-
tiation of chondrocytes following culture in monolayer con-
ditions on plastic [12,18,21–26]. However, few studies have
systematically addressed the de-differentiation}re-differentiation
process exhibited by human chondrocytes.
We have shown here that the decrease in expression
of chondrocyte-specific genes observed in de-differentiating
chondrocytes is largely controlled at the level of gene tran-
scription. These findings support previous work by Maatta et al.
[45], in which it was shown that de-differentiating human
chondrocytes initiate expression of transcription factors that
bind to an AP-1 (activator protein 1) site located in the first
intron of the non-cartilage-specific COL1A1 gene. Furthermore,
they showed that a mutation in this AP-1-binding site resulted in
substantially lower expression of a COL1A1 reporter plasmid
in the de-differentiating chondrocytes. These results suggest
that up-regulation of genes associated with the de-differentiated
phenotype such as those encoding the interstitial type-I and -III
collagens may be mediated by an increase in the level of certain
transcription factors as a mechanism for the phenotypic switch.
In support of this notion, it has been shown previously that de-
differentiating chondrocytes express greater levels of the tran-
scription factors Sp1 and nuclear factor-jB and lower levels of
C-Krox [29,46]. Interestingly, Sp1 is a positive regulator of the
COL1A1 gene, but the mechanism controlling the de-
differentiation}re-differentiation process appears more complex
since Sp-1 is known to also stimulate the expression of the human
COL2A1 gene [29,47,48]. Thus it is very likely that other
transcription factors which control the chondrocyte-specific gene
expression pattern are concomitantly down-regulated during de-
differentiation. Here we have shown that the pattern of nuclear-
factor binding to a region of the human COL2A1 first-intron
enhancer changes upon de-differentiation of the chondrocytes.
Indeed, our studies indicate that these factors are SOX tran-
scription factors (SOX6, SOX9 and L-SOX5), which have been
implicated previously in the positive regulation of both mouse
and human COL2A1 genes through binding to the same region
of the first-intron enhancer contained within the probe that we
employed. These results are supported by the findings of Lefebvre
and colleagues [33,34], who showed that mRNA for the SOX9
transcription factor is down-regulated during de-differentiation
of mouse rib chondrocytes. We have also shown that expres-
sion of the chondrocyte-specific gene COL2A1 can be activated in
de-differentiated cells by ectopic expression of the SOX factors.
Interestingly, our results showed that co-expression of three SOX
transcription factors, L-SOX5, SOX6 and SOX9, was more
effective than any of the transcription factors alone in activating
a human COL2A1 promoter}enhancer reporter construct in de-
differentiated bovine chondrocytes. Elegant work by Lefebvre et
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al. [34] has shown that L-SOX5 and SOX6 co-operate with
SOX9 to activate the mouse COL2A1 gene through the enhancer
region. In agreement with our results, they showed that all three
SOX factors were required for high-level activation of the
COL2A1 gene in both undifferentiated C3H101}2 mesenchymal
cells and a SV40-transformed mouse embryonic limb carti-
lage cell line (MC615 cells) that had lost their chondrocyte
phenotype through repeated passaging. These findings provide a
better understanding of the regulation of the chondrocyte-specific
phenotype, indicating that factors which modulate the expression
of the SOX genes could enable a more efficient reversal to this
phenotype. This is especially noteworthy since the maintenance
of the chondrocyte-specific phenotype is of crucial importance to
the preservation of the structure and biomechanical properties of
cartilage, and alterations in the production of cartilage-specific
collagens that occur when chondrocytes become de-differentiated
will obviously affect severely the function of the tissue. Although
there is abundant literature demonstrating a change in the
pattern of extracellular matrix molecules synthesized by
chondrocytes undergoing de-differentiation during culture as a
monolayer on plastic, certain therapeutic approaches for treat-
ment of articular cartilage defects incorporate an extended ex
io expansion phase with multiple passages in monolayer
cultures followed by re-implantation of the cells [49–52]. Fur-
thermore, ex io expansion of chondrocytes followed by re-
implantation of the cells is now being explored for treatment of
degenerative joint diseases [49]. Therefore further study into the
mechanisms that determine the chondrocyte-specific phenotype
in itro and into conditions that allow its preservation and
recovery is needed to develop these therapies fully. Research
aimed at elucidating these mechanisms and their control will
undoubtedly lead to better ways to modulate the chondrocyte
phenotype in itro and thereby improve the ability to implement
gene- and cell-therapy approaches for various heritable and
acquired cartilage diseases.
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